Is 3M Spinoff Solventum a Buy? (And What It Means for 3M Investors)
The Motley Fool
MAY 17, 2024
First, 3M saddled Solventum with debt to shore up the balance sheet of the former as it faces multibillion-dollar legal settlements. As for the 4%-6% expected end market growth, the figure looks familiar enough because it's what 3M's management told investors to expect from its healthcare end market on 3M's investor day in 2016 and 2019.
Let's personalize your content